Treatment of vaginal carcinoma with laser photoirradiation following administration of haematoporphyrin derivative. Report of a case.
Laser photoirradiation therapy following the administration of haematoporphyrin derivative (HpD) was performed in a case of primary vaginal carcinoma (stage I) using red light from an argon laser source. The vaginal tumor was destroyed and disappeared completely. No recurrence has been observed during a one-year follow-up. The findings suggest that HpD and laser photoradiation therapy may be effective in the treatment of early vaginal carcinoma.
D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000473:pathology / Q000601:surgery*; D005260:Female; D017324:Hematoporphyrin Derivative; D006415:Hematoporphyrins / Q000627:therapeutic use*; D006801:Humans; D053685:Laser Therapy; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use*; D014625:Vaginal Neoplasms / Q000473:pathology / Q000601:surgery*
D006415:Hematoporphyrins; D011838:Radiation-Sensitizing Agents; D017324:Hematoporphyrin Derivative